Why BioMarin Pharmaceutical, Bristol-Myers Squibb, and bluebird bio Are Getting Hammered MondayThe Motley Fool • 03/16/20
Why Biotech Stocks AnaptysBio, bluebird bio, and Editas Medicine Are Sinking TodayThe Motley Fool • 03/12/20
Bluebird Bio (BLUE) Outpaces Stock Market Gains: What You Should KnowZacks Investment Research • 01/08/20
bluebird bio's Advancement With Zynteglo Gene Therapy Is Properly Set Up For Commercial SuccessSeeking Alpha • 12/16/19
Are Options Traders Betting on a Big Move in bluebird (BLUE) Stock?Zacks Investment Research • 12/03/19
bluebird bio: Market Fails To React To Impressive Data On Lenti-D Gene Therapy For CALDSeeking Alpha • 09/23/19